TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23650802

Group type: EXPERIMENTAL
Intervention: Equilibrium acupuncture
Number of subjects: 287

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 287
Study: 21231790

Group type: EXPERIMENTAL
Intervention: Six-day multi-focus psychosocial residential rehabilitation intervention
Number of subjects: 507

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 507
Study: 19065655

Group type: EXPERIMENTAL
Intervention: DRD2 rs1799732 CT genotype
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DRD2 rs1800497 TT genotype
Number of subjects: 0
Study: 16861341

Group type: EXPERIMENTAL
Intervention: Chronic transfusion for primary stroke prevention
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Transfusion
Number of subjects: 108

Group type: COMPARATOR
Intervention: No transfusion
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: TCD results at last testing
Number of subjects: 108
Study: 12626983

Group type: EXPERIMENTAL
Intervention: Naloxone (8 mg four times daily via gastric tube)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (four times daily via gastric tube)
Number of subjects: 84
Study: 10827889

Group type: EXPERIMENTAL
Intervention: Exposure therapy guided by a computer or by a therapist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation guided by audio-tape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagery scenarios (OCD, non-OCD anxiety, neutral)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cancelling imagery
Number of subjects: 0
Study: 9209989

Group type: EXPERIMENTAL
Intervention: 0.1 cc unpreserved lidocaine 1%
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.1 cc balanced salt solution (BSS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5 cc unpreserved lidocaine 1%
Number of subjects: 0
Study: 7895788

Group type: EXPERIMENTAL
Intervention: Unilateral vestibular deafferentation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 23
Study: 2459788

Group type: EXPERIMENTAL
Intervention: Intravesical BCG therapy for superficial bladder cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics for urinary tract infections
Number of subjects: 0
Study: 29424805

Group type: EXPERIMENTAL
Intervention: Blonanserin (8 mg) with alcohol (1 mL/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Blonanserin (8 mg) with water
Number of subjects: 10
Study: 27768139

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 30
Study: 25015353

Group type: EXPERIMENTAL
Intervention: 100% oxygen breathing
Number of subjects: 41
Study: 23221984

Group type: EXPERIMENTAL
Intervention: HCV-infected women (HCV+)
Number of subjects: 868

Group type: COMPARATOR
Intervention: HCV-uninfected women (HCV-)
Number of subjects: 868
Study: 19712983

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20mg once daily
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 142
Study: 17848804

Group type: EXPERIMENTAL
Intervention: 80 microg ciclesonide for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 80 microg ciclesonide
Number of subjects: 0
Study: 16618294

Group type: EXPERIMENTAL
Intervention: Rectus sheath block
Number of subjects: 14

Group type: COMPARATOR
Intervention: Local anesthetic infiltration into the surgical wound
Number of subjects: 14
Study: 12489066

Group type: EXPERIMENTAL
Intervention: Combination therapy of voglibose plus a SU compound (glibenclamide or gliclazide)
Number of subjects: 124

Group type: COMPARATOR
Intervention: SU drug alone
Number of subjects: 124
Study: 9809728

Group type: EXPERIMENTAL
Intervention: Postoperative whole-brain radiotherapy (radiotherapy group, 49 patients)
Number of subjects: 95

Group type: COMPARATOR
Intervention: No further treatment (observation group, 46 patients)
Number of subjects: 95
Study: 7895348

Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (TPA) with intravenous heparin
Number of subjects: 41021

Group type: COMPARATOR
Intervention: Streptokinase with subcutaneous heparin
Number of subjects: 41021

Group type: COMPARATOR
Intervention: Streptokinase with intravenous heparin
Number of subjects: 41021

Group type: COMPARATOR
Intervention: Streptokinase plus TPA with intravenous heparin
Number of subjects: 41021

Group type: EXPERIMENTAL
Intervention: Coronary artery perfusion (TIMI grade 3) at 90 minutes
Number of subjects: 41021
Study: 2793316

Group type: EXPERIMENTAL
Intervention: Intraocular daunomycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intraocular drug (Control)
Number of subjects: 0
Study: 330288

Group type: EXPERIMENTAL
Intervention: Diclofenac (Voltaren) 100 mg twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diclofenac (Voltaren)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 30
Study: 6794075

Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxepin 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desipramine 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline and Doxepin
Number of subjects: 0
Study: 30897095

Group type: EXPERIMENTAL
Intervention: Improved infant and young child feeding (IYCF) - 20 g of small-quantity lipid-based nutrient supplement per day from age 6 to 18 months plus complementary feeding counseling
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Improved water, sanitation, and hygiene (WASH) - ventilated improved pit latrine, handwashing stations, chlorine, liquid soap, and play yard
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: WASH + IYCF
Number of subjects: 1655

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 1655
Study: 29030692

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (IVBe)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab with subtenon triamcinolone injection (IVBe + STTA)
Number of subjects: 23
Study: 26868602

Group type: EXPERIMENTAL
Intervention: Behavioral counseling combined with technology‐based self‐monitoring for sodium restriction
Number of subjects: 179

Group type: COMPARATOR
Intervention: Attention control group (received 6 educational modules on the HD diet)
Number of subjects: 179
Study: 24981150

Group type: EXPERIMENTAL
Intervention: Fennel
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Low-dose combined oral contraceptive (LD-COC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: LD-COC
Number of subjects: 78
Study: 21415280

Group type: EXPERIMENTAL
Intervention: Aprepitant (125 mg orally on day 1 and 80 mg orally on each consecutive day through day +4 after HSCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19173688

Group type: EXPERIMENTAL
Intervention: Cerebral state monitor (CSM) group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (usual clinical criteria)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: CSM group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 17262225

Group type: EXPERIMENTAL
Intervention: Modern clinical testing protocol for controlled clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Categories of assessment for esthetic evaluation, functional assessment, biological responses to restorative materials
Number of subjects: 0
Study: 15990669

Group type: EXPERIMENTAL
Intervention: Gravity line assessment in standing volunteers and patients with scoliosis
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Gravity line assessment in both study populations (volunteers and patients)
Number of subjects: 86
Study: 11940748

Group type: EXPERIMENTAL
Intervention: Jejunal feeding (JEN group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Gastric feeding (GEN group)
Number of subjects: 110
Study: 10321139

Group type: EXPERIMENTAL
Intervention: Functional appliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Headgear
Number of subjects: 0
Study: 7654798

Group type: EXPERIMENTAL
Intervention: Exercise group (3-month supervised group exercise program)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nonexercise group
Number of subjects: 42
Study: 2630378

Group type: EXPERIMENTAL
Intervention: self blood glucose monitoring, twice every other day
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: self-urine glucose monitoring, twice every other day
Number of subjects: 208

Group type: COMPARATOR
Intervention: regular HbA1c determinations but no self-monitoring
Number of subjects: 208
Study: 798128

Group type: EXPERIMENTAL
Intervention: L-dopa + G 31.406
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: L-dopa + chl. amantadine
Number of subjects: 60

Group type: COMPARATOR
Intervention: L-dopa + placebo
Number of subjects: 60
Study: 30626548

Group type: EXPERIMENTAL
Intervention: Bilateral double suspension sutures (DSS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bilateral single palatal suspension sutures (SSS)
Number of subjects: 0
Study: 28671093

Group type: EXPERIMENTAL
Intervention: TCM pulmonary rehabilitation therapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Routine treatment (Control group)
Number of subjects: 79
Study: 26073389

Group type: EXPERIMENTAL
Intervention: ERN-LRPT
Number of subjects: 11310

Group type: EXPERIMENTAL
Intervention: ERN-NSP
Number of subjects: 11310

Group type: COMPARATOR
Intervention: statin-PBO
Number of subjects: 11310
Study: 24156136

Group type: EXPERIMENTAL
Intervention: 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate (experimental)
Number of subjects: 446

Group type: COMPARATOR
Intervention: 1450 ppm fluoride as sodium monofluorophosphate (positive control)
Number of subjects: 446

Group type: COMPARATOR
Intervention: No fluoride (negative control)
Number of subjects: 446
Study: 21540202

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT) for fatigue self-management, comprising six weekly 2-hour sessions and a consolidation session at week 14.
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group receiving fatigue self-management information in a 1-hour didactic group session.
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT) for fatigue self-management.
Number of subjects: 127
Study: 19042929

Group type: EXPERIMENTAL
Intervention: Robotic camera holding (Ro)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Human camera holding (Hu)
Number of subjects: 38
Study: 16718764

Group type: EXPERIMENTAL
Intervention: Ecabet sodium (1.5 g twice a day)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Cimetidine (400 mg twice a day)
Number of subjects: 272
Study: 14729239

Group type: EXPERIMENTAL
Intervention: 5 mg of diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 12296675

Group type: EXPERIMENTAL
Intervention: Endotracheal tube cuff pressure adjusted to 20 mm Hg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no adjustment of ETCP)
Number of subjects: 51
Study: 9694180

Group type: EXPERIMENTAL
Intervention: Training in a patient‐centred intervention for GPs and practice nurses
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 252
Study: 7806810

Group type: EXPERIMENTAL
Intervention: Tinel's sign
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Elbow flexion test
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pressure provocation test
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combined elbow flexion and pressure provocation test
Number of subjects: 32
Study: 2649864

Group type: EXPERIMENTAL
Intervention: Surfactant treatment
Number of subjects: 61
Study: 15467

Group type: EXPERIMENTAL
Intervention: Fazadinium 1 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fazadinium 1-25 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Suxamethonium 1 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcuronium 0-32 mg/kg
Number of subjects: 0
Study: 30871544

Group type: EXPERIMENTAL
Intervention: iFightDepression® tool
Number of subjects: 360

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (control condition)
Number of subjects: 360
Study: 28894017

Group type: EXPERIMENTAL
Intervention: Early integrated palliative care (PC)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Oncology care alone
Number of subjects: 275
Study: 25312518

Group type: EXPERIMENTAL
Intervention: Schema-Based Instruction (SBI)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 260
Study: 25555887

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment for 4 weeks followed by dose tapering over 7 days
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment for 4 weeks followed by dose tapering over 28 days
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment for 4 weeks followed by dose tapering over 7 or 28 days
Number of subjects: 516
Study: 21975470

Group type: EXPERIMENTAL
Intervention: Systematic back muscle exercise (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General postoperation therapy (Group A)
Number of subjects: 60
Study: 19875311

Group type: EXPERIMENTAL
Intervention: GS=1 (single items, i.e., 12 x 1 item)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: GS=3 (4 x 3 items)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: GS=6 (2 x 6 items)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: GS=12 (standard presentation mode, i.e., 1 x 12 items)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Temporal grouping and grouped overt rehearsal
Number of subjects: 126
Study: 17873305

Group type: EXPERIMENTAL
Intervention: Weekly docetaxel (30 mg/m2), epirubicin (30 mg/m2), and carboplatin (AUC 2) with filgrastim support
Number of subjects: 72
Study: 15625814

Group type: EXPERIMENTAL
Intervention: Budesonide through Nebuchamber
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate through Babyhaler
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Nebuchamber
Number of subjects: 69
Study: 11518846

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment withdrawal (group A1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment withdrawal (group A2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment (group B)
Number of subjects: 20
Study: 9220100

Group type: EXPERIMENTAL
Intervention: Allen test performed by four physician examiners
Number of subjects: 200
Study: 8240556

Group type: EXPERIMENTAL
Intervention: Actidose Aqua AC (1,500 m2/g)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Norit A Supra AC (2,000 m2/g)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control phase (no AC administered)
Number of subjects: 5
Study: 2822337

Group type: EXPERIMENTAL
Intervention: Nabilone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 40
Study: 29357358

Group type: EXPERIMENTAL
Intervention: Psychological intervention programme (cognitive therapy, relaxation therapy, emotional support)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no psychological intervention)
Number of subjects: 60
Study: 27624471

Group type: EXPERIMENTAL
Intervention: 800 mg ferroquine
Number of subjects: 8
Study: 23954043

Group type: EXPERIMENTAL
Intervention: Combination of health marks and traffic light colour-coding
Number of subjects: 160

Group type: COMPARATOR
Intervention: Health marks only
Number of subjects: 160

Group type: COMPARATOR
Intervention: Traffic light colours only
Number of subjects: 160
Study: 22134388

Group type: EXPERIMENTAL
Intervention: Felodipine with Irbesartan
Number of subjects: 160

Group type: COMPARATOR
Intervention: Felodipine with Metoprolol
Number of subjects: 160
Study: 21029646

Group type: EXPERIMENTAL
Intervention: Coronary artery variation (variant group)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Usual coronary arteries (usual group)
Number of subjects: 280
Study: 18772303

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 15903387

Group type: EXPERIMENTAL
Intervention: WL
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: VJ
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 14755115

Group type: EXPERIMENTAL
Intervention: Formulation I of ramipril (5 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Formulation II of ramipril (5 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both formulations of ramipril (5 mg)
Number of subjects: 36
Study: 10864982

Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 600 microg and PO dexamethasone at 8 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 450 microg and PO dexamethasone at 8 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 450 microg and PO dexamethasone at 12 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 450 microg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PO dexamethasone at 12 mg
Number of subjects: 5
Study: 8900983

Group type: EXPERIMENTAL
Intervention: Cross‐coupled rotation with varying gyroscopic angular acceleration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross‐coupled rotation with or without restriction of head movement
Number of subjects: 0
Study: 1412655

Group type: EXPERIMENTAL
Intervention: Ivermectin (high doses)
Number of subjects: 0
Study: 4015937

Group type: EXPERIMENTAL
Intervention: Chlormethiazole infusion 10 ml min‐1 over 16 (+/‐ 6) min
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Diazepam loading dose of 20 (+/‐ 15) mg at a rate of 1 mg min‐1
Number of subjects: 21
Study: 30206618

Group type: EXPERIMENTAL
Intervention: Plant sterol-enriched beverage (2 g of PS added)
Number of subjects: 38
Study: 27690741

Group type: EXPERIMENTAL
Intervention: Dupilumab every other week (300 mg)
Number of subjects: 1379

Group type: EXPERIMENTAL
Intervention: Dupilumab weekly (300 mg)
Number of subjects: 1379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1379

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 1379
Study: 25311083

Group type: EXPERIMENTAL
Intervention: Late Eating (LE; lunch at 16:30)
Number of subjects: 32
Study: 24094791

Group type: EXPERIMENTAL
Intervention: Attention training (n=15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo/control (n=16)
Number of subjects: 31
Study: 19926594

Group type: EXPERIMENTAL
Intervention: Nurse-led multidisciplinary intervention
Number of subjects: 750

Group type: COMPARATOR
Intervention: Usual post-discharge care
Number of subjects: 750
Study: 18257045

Group type: EXPERIMENTAL
Intervention: CD-ROM-based educational intervention on anticoagulation guidelines
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no CD-ROM intervention)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: CD-ROM-based educational intervention
Number of subjects: 117
Study: 16616348

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 14668709

Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-osmolar agents
Number of subjects: 0
Study: 10999872

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg and dry powder budesonide 100 microg twice daily
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo and dry powder budesonide 200 microg twice daily
Number of subjects: 27
Study: 8771064

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) injection around one eye
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline solution injection around the other eye (Control)
Number of subjects: 6
Study: 1466596

Group type: EXPERIMENTAL
Intervention: Modified Health Assessment Questionnaire (MHAQ)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Health Assessment Questionnaire (HAQ)
Number of subjects: 100
Study: 6366150

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX) regimen
Number of subjects: 38

Group type: COMPARATOR
Intervention: Regular follow-up without primary adjuvant chemotherapy
Number of subjects: 38
Study: 31509202

Group type: EXPERIMENTAL
Intervention: Housing First Intervention with Intensive Case Management
Number of subjects: 31

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 31
Study: 29108530

Group type: EXPERIMENTAL
Intervention: Approach-avoidance training (AAT) for food cues
Number of subjects: 59
Study: 27302673

Group type: EXPERIMENTAL
Intervention: Nordic school meals
Number of subjects: 834

Group type: COMPARATOR
Intervention: Packed lunch from home (control)
Number of subjects: 834
Study: 27129008

Group type: EXPERIMENTAL
Intervention: Testosterone gel 1%
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Testosterone gel 2%
Number of subjects: 11

Group type: COMPARATOR
Intervention: Testogel
Number of subjects: 11
Study: 22834852

Group type: EXPERIMENTAL
Intervention: MOMS program (eight structured classes starting in the first trimester of pregnancy, occurring every other week until the third trimester)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: MOMS program
Number of subjects: 65

Group type: COMPARATOR
Intervention: Usual prenatal care (control group)
Number of subjects: 65
Study: 21054291

Group type: EXPERIMENTAL
Intervention: Speed-of-processing training
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Reasoning training
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 908

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 908
Study: 17652452

Group type: EXPERIMENTAL
Intervention: Sublingual 400 microg misoprostol and 100 mg diclofenac
Number of subjects: 80

Group type: COMPARATOR
Intervention: 100 mg diclofenac alone (control group)
Number of subjects: 80
Study: 15977880

Group type: EXPERIMENTAL
Intervention: Intacs inserts
Number of subjects: 37
Study: 12148189

Group type: EXPERIMENTAL
Intervention: 1/3 patellar tendon graft (B‐T‐B) with sutures on screws or staples, 4-5 week immobilisation post-op
Number of subjects: 38

Group type: COMPARATOR
Intervention: Graft fixation with interferential screws, no post-op immobilisation
Number of subjects: 38